MetLife, Inc. (MET) has been recognized among the best health insurance stocks, with rising expectations for a significant buy position by 2025. The company had a mixed 2024 performance, with a noted full-year and fourth quarter earnings which fell slightly short of estimates; however, they were successful in maintaining a robust financial performance with a strong recovery and growth. Interestingly, MET has been included in Fortune's Most Admired Companies list and declared one of the top 25 global workplaces for 2024, reflecting its sound organizational credibility. Multiple firms, such as Jennison Associates LLC, Foundations Investment Advisors LLC, and Kingswood Wealth Advisors LLC, have increased their positions in MET shares, indicative of the company's promising prospects. A number of establishments, however, have reduced their stake in MET, displaying divergent market sentiments. In a strategic expansion move, MetLife Investment Management acquired PineBridge Investments and Traditional Fixed Income from Mesirow. The company has also targeted double-digit earnings per share growth, applied in its 'New Frontier' strategy. Despite a five-year earning decline, shareholder returns rose by 107%. The stock also met the 80-Plus Relative Strength Rating threshold.
Metlife MET News Analytics from Tue, 25 Jun 2024 07:00:00 GMT to Sat, 08 Feb 2025 21:03:23 GMT -
Rating 5
- Innovation 3
- Information 6
- Rumor 1
